CN113197879B - 一种神经酸微胶囊及其制备方法 - Google Patents
一种神经酸微胶囊及其制备方法 Download PDFInfo
- Publication number
- CN113197879B CN113197879B CN202110579043.XA CN202110579043A CN113197879B CN 113197879 B CN113197879 B CN 113197879B CN 202110579043 A CN202110579043 A CN 202110579043A CN 113197879 B CN113197879 B CN 113197879B
- Authority
- CN
- China
- Prior art keywords
- nervonic acid
- magnetic field
- emulsion
- 5min
- stirring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
样品1 | 样品2 | |
粒径 | 127nm | 37nm |
分散系数 | 0.32 | 0.11 |
包埋率 | 84% | 92% |
释药率 | 73% | 95% |
稳定性(常温常压) | 14天 | 20天以上 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110579043.XA CN113197879B (zh) | 2021-05-26 | 2021-05-26 | 一种神经酸微胶囊及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110579043.XA CN113197879B (zh) | 2021-05-26 | 2021-05-26 | 一种神经酸微胶囊及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113197879A CN113197879A (zh) | 2021-08-03 |
CN113197879B true CN113197879B (zh) | 2022-10-11 |
Family
ID=77023303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110579043.XA Active CN113197879B (zh) | 2021-05-26 | 2021-05-26 | 一种神经酸微胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113197879B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101579334A (zh) * | 2009-06-12 | 2009-11-18 | 李仲昆 | 一种由神经酸、姜黄素组成的复合制剂 |
CN106262927A (zh) * | 2016-08-15 | 2017-01-04 | 陕西科技大学 | 一种元宝枫油微胶囊及其制备方法 |
CN112544979A (zh) * | 2020-12-11 | 2021-03-26 | 广西科技大学 | 蒜头果油微胶囊的乳化工艺 |
-
2021
- 2021-05-26 CN CN202110579043.XA patent/CN113197879B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101579334A (zh) * | 2009-06-12 | 2009-11-18 | 李仲昆 | 一种由神经酸、姜黄素组成的复合制剂 |
CN106262927A (zh) * | 2016-08-15 | 2017-01-04 | 陕西科技大学 | 一种元宝枫油微胶囊及其制备方法 |
CN112544979A (zh) * | 2020-12-11 | 2021-03-26 | 广西科技大学 | 蒜头果油微胶囊的乳化工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN113197879A (zh) | 2021-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107205950A (zh) | 金刚烷胺组合物的施用方法 | |
KR102231129B1 (ko) | 수면 장애 치료용 발레리안 뿌리 추출물 및 라벤더 오일의 조합물 | |
CN108888670A (zh) | 一种治疗溃疡性结肠炎的结肠靶向胶囊剂及其制备工艺 | |
AU2020239829A1 (en) | Oral rapamycin nanoparticle preparations and use | |
CN1985851B (zh) | 含有蟾酥提取物的脂质微球注射液及其制备方法 | |
WO2019037682A1 (zh) | 用于调整肠道菌群的肠溶氧气微囊及其制备方法与用途 | |
CN113197879B (zh) | 一种神经酸微胶囊及其制备方法 | |
US20160022649A1 (en) | Use of inhibitors of mtor to improve vascular functions in apoe4 carriers | |
CN107412199B (zh) | 一种盐酸美金刚缓释胶囊组合物 | |
Zhao et al. | A novel neuroinflammation-responsive hydrogel based on mimicking naked mole rat brain microenvironment retards neurovascular dysfunction and cognitive decline in Alzheimer’s disease | |
CN115010790A (zh) | 纳米小肽fg及其在制备治疗及预防眼底血管疾病药物中的应用 | |
CN109496151A (zh) | 用于治疗疼痛的塞来昔布口服组合物 | |
CN113368182A (zh) | 一种预防或治疗糖尿病脑病的中药组合物及其用途 | |
CN106822762B (zh) | 一种质量稳定的风湿二十五味丸及其制备工艺 | |
JP2011513316A (ja) | 眼疾患の治療のための黒大豆の使用 | |
CN115006369B (zh) | 一种脑靶向类脂纳米囊载药系统及其制备方法和应用 | |
CN115777926B (zh) | 一种具有增强记忆改善认知的组合物及其应用 | |
CN107320468A (zh) | 复合磷脂脂质体口服液及其制备方法和应用 | |
CN113402587B (zh) | 一种八肽及其在制备改善记忆的药品中的应用 | |
CN108371712A (zh) | 咖啡因与PPARγ激动剂联合制备AD药物中的用途 | |
CN107281203A (zh) | 娑罗子提取物在制备防治老年痴呆药物中的应用 | |
CN116492327A (zh) | (2s,6s)-2,6-二氨基庚二酸在制备抗产后抑郁药物中的应用 | |
CN110237084A (zh) | 王百合苷a在制备抗抑郁药物中的应用 | |
CN114933635A (zh) | 纳米小肽fh及其在制备治疗及预防眼底血管疾病药物中的应用 | |
CN117771212A (zh) | 血竭素高氯酸盐固体脂质纳米粒及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20211229 Address after: 250101 108, floor 1, North building, No. 26, Xizhou South Road, Licheng District, Jinan City, Shandong Province Applicant after: Shandong Jiejing Jingwei Pharmaceutical Technology Co.,Ltd. Address before: 250100 No. 302, unit 3, building 2, No. 21, Hongjia building, Licheng District, Jinan City, Shandong Province Applicant before: Qin Shuoqing |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220908 Address after: 250101 108, floor 1, North building, No. 26, Xizhou South Road, Licheng District, Jinan City, Shandong Province Applicant after: Shandong Jiejing Jingwei Pharmaceutical Technology Co.,Ltd. Applicant after: Qin Shuoqing Address before: 250101 108, floor 1, North building, No. 26, Xizhou South Road, Licheng District, Jinan City, Shandong Province Applicant before: Shandong Jiejing Jingwei Pharmaceutical Technology Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230718 Address after: 250353 University Road, Changqing District, Ji'nan, Shandong Province, No. 3501 Patentee after: Qin Dawei Address before: 250101 108, floor 1, North building, No. 26, Xizhou South Road, Licheng District, Jinan City, Shandong Province Patentee before: Shandong Jiejing Jingwei Pharmaceutical Technology Co.,Ltd. Patentee before: Qin Shuoqing |